Carbamazepine hypersensitivity syndrome mimicking mycosis jungoides

Cutis

Volumn 67, Issue 1, 2001, Pages 47-51

  Miranda Romero, Alberto ^a,c   Pérez Oliva, Narciso ^b   Aragoneses, Henar ^a   Bastida, Jesús ^a   Raya, Cristina ^b   González Lopez, Antonio ^a   García Muñoz, Miguel ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE;

AGED; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MYCOSIS FUNGOIDES; SKIN TUMOR; SYNDROME;

AGED; ANTICONVULSANTS; CARBAMAZEPINE; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MYCOSIS FUNGOIDES; SKIN NEOPLASMS; SYNDROME;

EID: 0035229656     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Romaguera C. Erythroderma from carbamazepine. Contact Derm. 1989;20:304-330.
2. Breathnach SM, McGibbon DH, Ive FA, et al. Carbamazepine (Tegretol) and toxic epidermal necrolysis: report of three cases with histopathological observations. Clin Exp Dermatol. 1982;7:585-591.
3. Roustan G, Hospital M, López J, et al. Sindrome de Stevens-Johnson por carbamazepina e infección por VIH: una observación. Actas Dermosifiliogr. 1990;81:775-778.
4. Camarasa JG. Path test diagnosis of exfoliative dermatitis due to carbamazepine. Contact Derm. 1985;12:49.
5. Roberts DLL, Marks R. Skin reactions to carbamazepine. Arch Dermatol. 1981;117:273-275.
6. Terni T, Tagami H. Eczematous drug eruption from carbamazepine: coexistence of contact and photocontact sensitivity. Contact Derm. 1989;20:260-264.
7. Houwerzijl J, De Gast GC, Nater JP, et al. Lymphocyte-stimulation tests and patch test in carbamazepine hypersensitivity. Clin Exp Immunol. 1977;29:272-277.
8. Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol. 1991;127:1361-1364.
9. Sinnige HA, Boender CA, Kuypers EW, et al. Carbamazepine-induced pseudolymphoma and immune dysregulation. J Intern Med. 1990;227:355-358.
10. Puig L, Nadal C, Fernandez MT, et al. Carbamazepine-induced drug rashes: diagnostic value of patch test depends on clinico-pathologic presentation. Contact Derm. 1996;34:435-437.
11. Brenner S, Wolf R, Landau M, et al. Psoriasiform eruption induced by anticonvulsants. Isr J Med Sci. 1994;30:283-286.
12. Welykyj S, Gradini R, Nakao J, et al. Carbamazepine-induced eruption histologically mimicking mycosis fungoides. Cutan Pathol. 1990;17:111-116.
13. Rijlaarsdam U, Scheffer E, Meijer JL, et al. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol. 1991;24:216-220.
14. De Vriese SP, Philippe J, Van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine. 1995;74:144-151.
15. Silverman AK, Fairley J, Wong RC. Cutaneous and immunologic reactions to phenytoin. J Am Acad Dermatol. 1988;18:721-741.
16. D'Incan M, Souteyrand P, Bignon IJ, et al. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic and immunologic aspects of Sézary syndrome. Arch Dermatol. 1992;128:1371-1374.
17. Schreiber MM, McGregor JG. Pseudolymphoma syndrome. Arch Dermatol. 1968;97:297-300.
18. Rosenthat CJ, Noguera CA, Coppola A, et al. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation. Cancer. 1982;49:2305-2314.
19. Wolf R, Kahane E, Sandbank M. Mycosis fungoides-like lesions associated with phenytoin therapy. Arch Dermatol. 1985;121:1181-1182.
20. Souteyrand P, D'Incan M. Drug-induced mycosis-like lesions. Curr Probl Dermatol. 1990;19:176-182.
21. Cooke LE, Hardin TC, Hendrickson DJ. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations. Clin Pharm. 1998;7:153-157.
22. Ackerman AB, Breza TS, Capland L. Spongiotic simulants of mycosis fungoides. Arch Dermatol. 1974;109:218-220.
23. Fisher AA. Allergic contact dermatitis mimicking mycosis fungoides. Cutis. 1987;40:19-21.
24. Callot V, Roujeau J-C, Bagot M, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol. 1996;132:1315-1321.
25. Jones M, Fernández J, Dorado JM, et al. Epicutaneous test in carbamazepine cutaneous reactions. Dermatology. 1994;188:18-20.
26. Duhra P, Foulds IS. Structural specificity of carbamazepine-induced dermatitis. Contact Derm. 1992;27:325-326.
27. Zakrzewuska JM, Ivanyi L. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in diagnosis of drug-induced hypersensitivity. J Allergy Clin Immunol. 1998;82:110-115.
28. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest. 1988;82:1826-1832.
29. Gams RA, Neal JA, Conrad FG. Hydantoin-induced pseudo-pseudolymphoma. Ann Intern Med. 1968;69:557-568.